tiprankstipranks
Alzamend Neuro, Inc. (ALZN)
:ALZN
US Market

Alzamend Neuro (ALZN) Income Statement

Compare
307 Followers

Alzamend Neuro Income Statement

Last quarter (Q3 2025), Alzamend Neuro's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Alzamend Neuro's net income was $-1.04M. See Alzamend Neuro’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -50.74K$ -23.07K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 9.94M$ 14.87M$ 12.32M$ 4.95M$ 4.42M
Depreciation and Amortization
$ 50.74K$ 23.07K$ 3.55K$ 4.95M$ 4.42M
EBITDA
$ -9.89M$ -14.85M$ -12.32M$ 0.00$ 0.00
Operating Income
$ -9.94M$ -14.87M$ -12.32M$ -4.95M$ -4.42M
Other Income/Expenses
$ -10.10K$ -7.70K$ -42.52K$ -94.68K$ 13.93K
Pretax Income
$ -9.95M$ -14.88M$ -12.36M$ -5.05M$ -4.41M
Net Income
$ -9.95M$ -14.88M$ -12.40M$ -5.20M$ -4.40M
Per Share Metrics
Basic EPS
$ -14.72$ -22.89$ -20.92$ -10.75$ -9.26
Diluted EPS
$ -14.70$ -22.89$ -20.88$ -10.74$ -9.25
Weighted Average Shares Outstanding
3.38M 3.25M 2.96M 2.42M 2.38M
Weighted Average Shares Outstanding (Diluted)
3.38M 3.25M 2.97M 2.42M 2.38M
Currency in USD

Alzamend Neuro Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis